MedTrace Logo

Study of the Diagnostic Accuracy of the Neurodynamic Tests in Patients With Lumbar Radiculopathy

NCT05636917 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-12-05

No results posted yet for this study

Summary

Lumbar radiculopathy is a relevant cause of disability and morbidity, accounting for between 23 and 57% of the cases of patients with low back pain and representing a significant expense due to the sick leave and health care that may be required.

Nuclear magnetic resonance and electromyography are the most commonly used tests for the diagnosis of the pathology.

Neurodynamic tests represent a sequence of structured movements with the purpose of increasing the mechanical stress of the neural tissue. These tests are currently an important aspect of the physical examination of the patient when there is suspicion of neural involvement, allowing the physiological and mechanical capacities of the nerve to be evaluated.

The Slump and Straight Leg Raise neurodynamic tests are the two best known tests for assessing the mechanosensitivity of the sciatic nerve and its component roots.

The hypothesis of this observational study is that the straight leg raising and Slump neurodynamic tests with precise diagnostic criteria are valid tools for the diagnosis of lumbar radiculopathy.

Conditions

  • Lumbar Radiculopathy

Sponsors & Collaborators

  • Universidad de Zaragoza

    lead OTHER

Principal Investigators

  • Elena Bueno-Gracia, PT PhD · Universidad Zaragoza

  • Santos Caudevilla-Polo, PT PhD · Universidad Zaragoza

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2023-09-30
Completion
2023-09-04

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05636917 on ClinicalTrials.gov